Jara, Alejandro
Cuadrado, Cristobal
Undurraga, Eduardo A. http://orcid.org/0000-0002-4425-1253
García, Christian
Nájera, Manuel
Bertoglia, María Paz http://orcid.org/0000-0003-3631-0732
Vergara, Verónica
Fernández, Jorge http://orcid.org/0000-0002-5792-0719
García-Escorza, Heriberto
Araos, Rafael http://orcid.org/0000-0001-8075-0626
Article History
Received: 7 October 2022
Accepted: 25 September 2023
First Online: 27 October 2023
Competing interests
: R.A. has received consulting fees from AstraZeneca. R.A. and A.J. have received consulting fees from Pfizer and research support from Sinovac. This support is not related to this article. The remaining authors declare no competing interests.